Study,Country,Site,Subject,Visit,Projected Date,# Days Outstanding
Study 5,AUS,Site 2,Subject 2,EFFICACYFU2,30SEP2025,45
Study 5,AUS,Site 2,Subject 3,LONGTERMSAFETYFU1,30OCT2025,15
Study 5,AUS,Site 2,Subject 4,EFFICACYFU1,22OCT2025,23
Study 5,FRA,Site 277,Subject 2339,LONGTERMSAFETYFU1,11NOV2025,3
Study 5,FRA,Site 277,Subject 2345,CYCLE4WEEK3,05NOV2025,9
Study 5,FRA,Site 277,Subject 2347,CYCLE2WEEK3,28OCT2025,17
Study 5,ISR,Site 290,Subject 2406,EFFICACYFU3,11OCT2025,34
Study 5,ESP,Site 300,Subject 2512,CYCLE1WEEK3,08NOV2025,6
Study 5,ESP,Site 307,Subject 2569,CYCLE4WEEK1,18SEP2025,57
Study 5,ESP,Site 307,Subject 2570,EOT2SAFETYFU42D,12NOV2025,2
Study 5,NLD,Site 314,Subject 2585,CYCLE3WEEK3,06NOV2025,8
Study 5,CAN,Site 322,Subject 2630,SURVIVALFU1,09NOV2025,5
Study 5,CAN,Site 322,Subject 2633,CYCLE4WEEK3,06NOV2025,8
Study 5,USA,Site 333,Subject 2721,EFFICACYFU2,02NOV2025,12
Study 5,USA,Site 335,Subject 2733,CYCLE4WEEK3,12NOV2025,2
Study 5,USA,Site 336,Subject 2740,CYCLE2WEEK3,05NOV2025,9
Study 5,USA,Site 337,Subject 2745,CYCLE4WEEK3,30SEP2025,45
Study 5,USA,Site 337,Subject 2745,EOT2SAFETYFU42D,28OCT2025,17
Study 5,USA,Site 338,Subject 2751,CYCLE1WEEK3,02NOV2025,12
Study 5,USA,Site 338,Subject 2752,CYCLE1WEEK3,09NOV2025,5
Study 5,JPN,Site 198,Subject 1725,CYCLE1WEEK1,11APR2025,217
